As the European market experiences a positive shift with the STOXX Europe 600 Index rising by 3.00%, driven by optimism around geopolitical tensions easing in the Middle East, investors are keenly observing high-growth opportunities within the tech sector. In this environment, identifying promising tech stocks involves looking for companies that not only demonstrate innovative capabilities but also have strong adaptability to economic changes and inflation pressures, which are crucial given current market conditions.
Below we spotlight a couple of our favorites from our exclusive screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Kitron ASA is an electronics manufacturing services provider with operations across several countries including Norway, Sweden, and the United States, and has a market cap of NOK24.39 billion.
Operations: With a revenue of €846.40 million from its Electronics Manufacturing Services segment, Kitron ASA operates across multiple countries, focusing on delivering comprehensive electronic manufacturing solutions.
Kitron’s trajectory in the high-growth tech sector is underscored by its robust earnings growth, which at 24% annually outpaces the Norwegian market average of 10.2%. This performance is bolstered by strategic expansions, such as the planned construction of a new facility in Sweden to support defense programs, reflecting a proactive approach to scaling operations. Recent financials reveal a significant uptick in sales to EUR 272.7 million from EUR 164.6 million year-over-year, with net income also rising sharply to EUR 20 million from EUR 7.6 million. These figures highlight Kitron’s effective capitalization on increasing demand within its industry segments, particularly in defense and aerospace, where recent contracts worth tens of millions signify growing market trust and an expanding European footprint.
OB:KIT Earnings and Revenue Growth as at May 2026
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Vend Marketplaces ASA, along with its subsidiaries, develops and operates various marketplaces across Norway, Sweden, Finland, and Denmark with a market capitalization of NOK50.40 billion.
Operations: Vend Marketplaces ASA generates revenue through its diverse marketplace operations, with significant contributions from the Mobility segment (NOK2.56 billion) and Real Estate segment (NOK1.37 billion). The company’s business model focuses on leveraging its platforms across multiple Nordic countries to drive growth in these key areas.
Vend Marketplaces, navigating through a challenging tech landscape, has displayed a promising revenue growth rate of 9.3% annually, outpacing the Norwegian market’s average of 2.2%. Despite current unprofitability, projections indicate an impressive earnings growth potential at 100.67% per year over the next three years. The company’s commitment to innovation and market adaptation is further evidenced by its recent strategic share repurchases authorized for up to NOK 4 billion, aimed at enhancing capital structure and shareholder value. This move underscores Vend’s proactive approach in bolstering financial health and stakeholder confidence amidst its pursuit of profitability.
OB:VEND Earnings and Revenue Growth as at May 2026
Simply Wall St Growth Rating: ★★★★★☆
Overview: Kuros Biosciences AG focuses on the commercialization and development of biologic technologies for musculoskeletal care across the USA, EU, and internationally, with a market cap of CHF848.54 million.
Operations: Kuros Biosciences AG generates revenue primarily from its medical devices segment, which contributes $146.06 million. The company is involved in the development and commercialization of biologic technologies for musculoskeletal care across various regions, including the USA and EU.
Kuros Biosciences, with a notable turnaround from a net loss to reporting USD 2.55 million in net income last year, underscores its robust trajectory in the biotech sector. This leap was fueled by a significant revenue increase to USD 146.06 million from USD 85.16 million, marking an annual growth rate of 71.5%. The appointment of I.V. Hall as COO, bringing extensive medical device expertise, aligns with Kuros’s strategic focus on musculoskeletal applications and R&D innovation—critical as the company projects at least a 35% sales growth annually until 2028, aiming for sales between USD 300 million and USD 330 million. This leadership change and aggressive growth forecast reflect Kuros’s commitment to scaling operations and enhancing its market position amidst dynamic industry demands.
SWX:KURN Revenue and Expenses Breakdown as at May 2026
Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St’s portfolio, where intuitive tools await to help optimize your investment outcomes.
Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.
Contemplating Other Strategies?
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include OB:KIT OB:VEND and SWX:KURN.
Leave a comment